S. Chalfin

发表

Three-year outcomes of 324 prostate carcinoma patients treated with combination high-dose-rate brachytherapy and intensity modulated radiation therapy

K. Tokita, A. Mesa, J. Ravera, 2017 .

Sacral neuromodulation as an effective treatment for refractory pelvic floor dysfunction.

J. Kaptein, S. Chalfin, S. Aboseif, 2002, Urology.

Sacral neuromodulation in functional urinary retention: an effective way to restore voiding

J. Kaptein, S. Chalfin, S. Aboseif, 2002, BJU international.

Gross hematuria in a patient on chronic renal dialysis for the treatment of end stage renal disease secondary to nephrosclerosis.

S. Chalfin, D. Martin, T. Imray, 1981, The Journal of urology.

Neodymium-YAG laser: new treatment for urethral stricture disease.

A. Shanberg, S. Chalfin, L. Tansey, 1984, Urology.

The etiology of detrusor hyperreflexia in patients with infravesical obstruction.

W. Bradley, S. Chalfin, Stuart A. Chalfin, 1982, The Journal of urology.

Long-term clinical outcomes of 538 prostate carcinoma patients treated with combination high-dose-rate brachytherapy and external beam radiotherapy

K. Tokita, A. Mesa, J. Ravera, 2019, Journal of Radiation Oncology.

Polyethylene glycol hydrogel rectal spacer implantation in patients with prostate cancer undergoing combination high-dose-rate brachytherapy and external beam radiotherapy.

K. Tokita, A. Mesa, J. Ravera, 2016, Brachytherapy.